New federal rule requires drug intermediaries to disclose how they're paid
The companies that manage billions of dollars in prescription drug spending for employers and workers will soon be required to inform their clients all the different ways they get paid under a new rule released by the Trump administration Thursday. A final rule by the Department of Labor will require pharmacy benefit managers (PBMs) for...
Read the full story on The Hill → Opens the original article on thehill.comSummary aggregated from The Hill's public RSS feed. The full reporting belongs to The Hill — please read it on their site.